Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|16 Jun 2017||Submitted||Original manuscript|
|15 Aug 2017||Reviewed||Reviewer Report - Anita Mangia|
|27 Sep 2017||Reviewed||Reviewer Report - Mohammad Ruhul Quddus|
|2 Oct 2017||Reviewed||Reviewer Report - Ruth O'Regan|
|31 Oct 2017||Author responded||Author comments - María Florencia Mercogliano|
|Resubmission - Version 2|
|31 Oct 2017||Submitted||Manuscript version 2|
|13 Nov 2017||Reviewed||Reviewer Report - Anita Mangia|
|24 Nov 2017||Reviewed||Reviewer Report - Ruth O'Regan|
|4 Dec 2017||Author responded||Author comments - María Florencia Mercogliano|
|Resubmission - Version 3|
|4 Dec 2017||Submitted||Manuscript version 3|
|8 Dec 2017||Editorially accepted|
|28 Dec 2017||Article published||10.1186/s12885-017-3897-x|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.